Compare BZ & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BZ | RGEN |
|---|---|---|
| Founded | 2013 | 1981 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1B | 6.6B |
| IPO Year | 2021 | 1995 |
| Metric | BZ | RGEN |
|---|---|---|
| Price | $13.70 | $132.02 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 12 |
| Target Price | $23.00 | ★ $167.67 |
| AVG Volume (30 Days) | ★ 3.4M | 888.4K |
| Earning Date | 05-21-2026 | 05-05-2026 |
| Dividend Yield | ★ 1.24% | N/A |
| EPS Growth | N/A | ★ 286.96 |
| EPS | N/A | ★ 0.15 |
| Revenue | N/A | ★ $141,236,000.00 |
| Revenue This Year | $15.92 | $14.30 |
| Revenue Next Year | $12.78 | $14.52 |
| P/E Ratio | ★ $22.61 | $886.67 |
| Revenue Growth | N/A | ★ 35.10 |
| 52 Week Low | $12.85 | $100.99 |
| 52 Week High | $25.26 | $175.77 |
| Indicator | BZ | RGEN |
|---|---|---|
| Relative Strength Index (RSI) | 48.90 | 61.61 |
| Support Level | $13.02 | $130.40 |
| Resistance Level | $14.77 | $172.45 |
| Average True Range (ATR) | 0.59 | 5.37 |
| MACD | -0.02 | 0.90 |
| Stochastic Oscillator | 39.40 | 76.17 |
Kanzhun's Boss Zhipin job platform connects job seekers and employers. Boss Zhipin is China's largest online recruitment platform based on monthly active users, or MAU, and was established in 2014. Kanzhun earns revenue by providing services to enterprise customers primarily through its mobile app, which promotes engagement between recruiters and workers and operates on a recommendation basis powered by artificial intelligence. The platform specializes in transportation, logistics, construction, and service-based industries. About 85% of the companies looking to hire are small and medium-size enterprises. Its main competitors are 58.com, 51job, and Zhilian Zhaopin. Tencent has a 9.2% stake in Kanzhun.
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.